Imaging of non-small-cell lung cancer with Indium-111 pentetreotide

Clinical Nuclear Medicine

Volumn 25, Issue 1, 2000, Pages 24-28

  Lau, Sean K ^a   Johnson, D Scott ^b   Coel, Marc N ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c QUEEN S MEDICAL CENTER   (United States)

Author keywords

Non Small Cell Lung Cancer; Pentetreotide; Somatostatin

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; LUNG SQUAMOUS CELL CARCINOMA; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PLEURA BIOPSY; PLEURA EFFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORACOCENTESIS; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033982606     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200001000-00006     Document Type: Article

References (29)

1. Cancer Facts & Figures 1999. Surveillance Research. Atlanta: American Cancer Society, 1999.
2. Bastin KT, Curley R: Non-small-cell lung carcinoma. Current and future therapeutic management. Drugs 49:362, 1995.
3. Kwekkeboom DJ, Kho GS, Lamberts SW, et al: The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 21:1106, 1994.
4. Ihde DC, Minna JD: Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. Curr Probl Cancer 15:61, 1991.
5. Ihde DC, Minna JD: Non-small cell lung cancer. Part II: Treatment. Curr Probl Cancer 15:105, 1991.
6. Quint LE, Francis IR, Wahl RL, et al: Preoperative staging of non-small-cell carcinoma of the lung: Imaging methods. AJR 164:1349, 1995.
7. Armstrong P, Vincent JM: Staging non-small cell lung cancer. Clin Radiol 48:1, 1993.
8. Pearson FG: Staging of the mediastinum. Chest 103:346S, 1993.
9. Lamberts SW, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Reviews 12:450, 1991.
10. 3-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716, 1993.
11. Olsen JO, Pozderac RV, Hinkle G, et al: Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide. Semin Nucl Med 25:251, 1995.
12. Krenning EP, Kwekkeboom DJ, Reubi JC, et al: 111 In-octreotide scintigraphy in oncology. Metabolism 41:83, 1992.
13. Hofland LJ, Visser-Wisselaar HA, Lamberts SW: Somatostatin analogs: Clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50:287, 1995.
14. Reubi JC, Laissue J, Krenning E, Lamberts SW: Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Molec Biol 43:27, 1992.
15. Lamberts SW, Reubi JC, Krenning EP: Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors. J Steroid Biochem Molec Biol 43:185, 1992.
16. Reubi JC, Kovals L, Krenning E, Lamberts SW: Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 39:78, 1990.
17. Lamberts SW, Bakker WH, Reubi JC, Krenning EP: Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 323:1246, 1990.
18. Kwekkeboom DJ, Kho GS, Lamberts SW, et al: The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 21:1106, 1994.
19. Kirsch CM, von Pawel J, Grau I, Tatsch K: Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med 21:1318, 1994.
20. Reubi JC, Wasser B, Sheppard M, Macaulay V: Somatostatin receptors are present in small-cell but not in non-small cell lung carcinomas. Int J Cancer 45:269, 1990.
21. Reubi JC, Kvols L, Krenning EP, Lamberts SW: In vitro and in vivo detection of somatostatin receptors in human malignant tissues. Acta Oncologica 30:463, 1991.
22. Reubi JC: Neuropeptide receptors in health and disease. J Nucl Med 36:1825, 1995.
23. Sagman U, Mullen JB, Kovacs K, et al: Identification of Somatostatin receptors in human small cell lung carcinoma. Cancer 15:2129, 1990.
24. O'Byrne KJ, Halmos G, Pinski J, et al: Somatostatin receptor expression in lung cancer. Eur J Cancer 30A:1682, 1994.
25. Van Hagen PM, Krenning EP, Kwekkeboom DJ, et al: Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest 24:91, 1994.
26. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ: Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264:949, 1989.
27. Reubi JC, Horisberger U, Laissue J: High density of Somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? Int J Cancer 56:681, 1994.
28. Bury T, Dowlati A, Paulus P, et al: Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 10:2529, 1997.
29. Schiepers C: Role of positron emission tomography in the staging of lung cancer. Lung Cancer 17(Suppl 1):S29, 1997.